livemint.com
24.05.2021 / 08:49
53%
779
Roche's drug to treat Covid now available in India: Check price, who can take it
antibody cocktail on Monday for the treatment of mild to moderate Covid-19 patients who are at high risk."The first batch of the antibody cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June," said Cipla and Roche in a joint statement."In total, they can potentially benefit 2,00,000 patients as each of the 1,00,000 packs that will be available in India offers treatment for two patients," they added.Cipla has stated that it will distribute the product by leveraging its strong distribution strengths across the country.The Central Drugs Standards Control Organisation (CDSCO) had recently provided an emergency use authorisation to the antibody cocktail in India.